How did banning CFC’s in inhalers change children’s albuterol use?

Aaron Carroll

February 3, 2017

In 2009, the FDA banned the use of chlorofluorocarbons in albuterol inhalers. This meant that all of the generic inhalers (which contained CFCs) were pulled from the shelves. As pharmaceutical companies saw the ban coming, some CFC-free hydroflouroalkane (HFA) inhalers had been brought to market in the years prior. These new inhalers were, of course, branded and more expensive than generic inhalers.

What happened next will shock you! Well, maybe not. But the research on the topic is interesting and worth a read. Go now to my latest post over at the AcademyHealth blog!

@aaronecarroll

Health Policy
AcademyHealth, asthma, CFC, inhalers, research

Hidden information below

Aaron Carroll

Aaron E. Carroll, MD, MS is co-Editor-in-Chief of The Incidental Economist and tweets at @aaronecarroll. He is the Chief Health Officer at Indiana University. He is also a Distinguished Professor of Pediatrics and Associate Dean for Research Mentoring at the Indiana University School of Medicine. In addition to contributing regularly to The New York Times and the Atlantic, he is the author of four books, most recently The Bad Food Bible.

How did banning CFC’s in inhalers change children’s albuterol use?

Hidden information below

Aaron Carroll

The Incidental Economist

Editors In Chief

Managing Editor

Subscribe